An integrated platform at the intersection of biology, devices, and data.
4th State Medical is developing regenerative biologics, intelligent medical devices, clinical evidence, and connected technology as a single, coherent platform — with a long-term vision for AI-powered analytics across regenerative medicine.
Four disciplines, one platform.
Each discipline is developed independently under its own scientific, engineering, and regulatory rigor — and together forms a coherent regenerative medicine platform.
Formulations and delivery systems informed by decades of regenerative and cell-based research, developed under disciplined characterization and manufacturing controls.
A concept device platform designed for connected operation, consumable authentication, lot tracking, usage logging, and clinical workflow integration.
A structured evidence strategy spanning preclinical work, investigator-led collaborations, and long-term outcomes capture.
Cloud connectivity, data services, and future AI-compatible architecture supporting quality, safety, and utilization insight.
A platform, not a product.
We believe regenerative medicine will be defined by companies that combine biology, devices, evidence, and data under a single operating discipline.
- 01Platform breadth across biologics, devices, and data — not a single-product story.
- 02Scientific foundation informed by Dr. Jonathan Lakey's research and collaborators.
- 03Defensible IP layered across composition, device architecture, and data workflow.
- 04Structured regulatory and quality strategy aligned with 21 CFR 820 / ISO 13485.
- 05Long-term optionality across therapeutics, devices, education, and platform services.
Detailed materials are available to authorized investors only.
The investor portal contains confidential company, scientific, regulatory, financial, and data-room materials protected by an access code. Access is granted on a case-by-case basis and is subject to non-disclosure obligations.
- Investment ThesisRestricted
- Company OverviewRestricted
- Market OpportunityRestricted
- LeadershipRestricted
- Scientific AssetsRestricted
- Intellectual PropertyRestricted
- Product & Development PipelineRestricted
- Regulatory StrategyRestricted
- Commercial RoadmapRestricted
- Financial ProjectionsRestricted
- MilestonesRestricted
- Investor UpdatesRestricted
- Controlled Data RoomRestricted
Long-term platform economics.
Beyond initial products, 4th State Medical is architected to accumulate scientific, device, evidence, and data assets that compound over time.
Every clinical interaction — over time — contributes to a growing body of characterization, outcomes, and utilization data.
Biologics, devices, consumables, and software designed to interoperate, with authentication and lot tracking at the core.
The platform opens multiple long-term revenue paths across biologics, devices, education, and data services.